Induction of RIPK3/MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect
文献类型:期刊论文
作者 | Guo,Xiuping; Li,Rui; Cui,Jinjin; Hu,Chujuan; Yu,Haoyang; Ren,Ling; Cheng,Yangyang; Jiang,Jiandong; Ding,Xiao; Wang,Lulu |
刊名 | FRONTIERS IN PHARMACOLOGY
![]() |
出版日期 | 2023 |
卷号 | 14页码:1219362 |
关键词 | Erigeron breviscapus injection Dengzhanxixin Erigeron breviscapus (Vant ) Hand -Mazz colorectal cancer necroptosis drug resistance TUMOR-NECROSIS-FACTOR COLORECTAL-CANCER NATURAL COMPOUNDS SCUTELLARIN APOPTOSIS PROLIFERATION MACROPHAGES MIGRATION INVASION THERAPY |
ISSN号 | 1663-9812 |
DOI | 10.3389/fphar.2023.1219362 |
英文摘要 | Colorectal cancer (CRC) is the second leading cause of tumor-related deaths worldwide. Resistance of tumor cells to drug-induced apoptosis highlights the need for safe and effective antitumor alternatives. Erigeron breviscapus (Dengzhanxixin in China) injection (EBI), extracted from the natural herb Erigeron breviscapus (Vant.) Hand.-Mazz (EHM), has been widely used in clinical practice for cardiovascular diseases. Recent studies have suggested that EBI's main active ingredients exhibit potential antitumor effects. This study aims to explore the anti-CRC effect of EBI and elucidate the underlying mechanism. The anti-CRC effect of EBI was evaluated in vitro using CCK-8, flow cytometry, and transwell analysis, and in vivo through a xenograft mice model. RNA sequencing was utilized to compare the differentially expressed genes, and the proposed mechanism was verified through in vitro and in vivo experiments. Our study demonstrates that EBI significantly inhibits the proliferation of three human CRC cell lines and effectively suppresses the migration and invasion of SW620 cells. Moreover, in the SW620 xenograft mice model, EBI markedly retards tumor growth and lung metastasis. RNA-seq analysis revealed that EBI might exert antitumor effects by inducing necroptosis of tumor cells. Additionally, EBI activates the RIPK3/MLKL signaling pathway, a classical pathway of necroptosis and greatly promotes the generation of intracellular ROS. Furthermore, the antitumor effect of EBI on SW620 is significantly alleviated after the pretreatment of GW806742X, the MLKL inhibitor. Our findings suggest that EBI is a safe and effective inducer of necroptosis for CRC treatment. Notably, necroptosis is a non-apoptotic programmed cell death pathway that can effectively circumvent resistance to apoptosis, which provides a novel approach for overcoming tumor drug resistance. |
学科主题 | Pharmacology & Pharmacy |
WOS记录号 | WOS:001019088900001 |
源URL | [http://ir.kib.ac.cn/handle/151853/74969] ![]() |
专题 | 中国科学院昆明植物研究所 |
推荐引用方式 GB/T 7714 | Guo,Xiuping,Li,Rui,Cui,Jinjin,et al. Induction of RIPK3/MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect[J]. FRONTIERS IN PHARMACOLOGY,2023,14:1219362. |
APA | Guo,Xiuping.,Li,Rui.,Cui,Jinjin.,Hu,Chujuan.,Yu,Haoyang.,...&Wang,Lulu.(2023).Induction of RIPK3/MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect.FRONTIERS IN PHARMACOLOGY,14,1219362. |
MLA | Guo,Xiuping,et al."Induction of RIPK3/MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect".FRONTIERS IN PHARMACOLOGY 14(2023):1219362. |
入库方式: OAI收割
来源:昆明植物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。